A good prognosis rate is observed in those cancer patients where KLRB1 is highly upregulated as infiltration of immune cells at tumor site and sensitivity to chemotherapy is KLRB1-dependent in many cancer types (Cheng et al., 2022). Here, KLRB1 is linked to neoplasm.